🚨 Winter Storm Update for Tuesday, Feb. 13 🚨
The purpose of this study is to demonstrate that untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.
Sponsor:
Ascensia Diabetes Care
Information provided by (Responsible Party):
Ascensia Diabetes Care
NYSCC
New York, New York
5/1 – 5/2
Booth 519
Excipient World
Orlando, Florida
5/13 – 5/14
Booth 101
Corporate Headquarters and Labs
70 New Dutch Ln
Fairfield, NJ 07004
973-576-5957
Second Clinical Lab Location
304 Wootton St.
Boonton, NJ 07005
FDA
Registration# 1000151293
DEA
Registration# RC0199744 (Analytical Lab)
Schedule I-V license
Remember, Schedules I-II require DEA Form 222
Registration# RC0171568 (Researcher)
US EPA/NJ DEP
Registration# NJD982726648